BPC 157 Dosing (Common Protocols) Oral Subcutaneous 500 mcg daily Duration: 6 weeks Intramuscular Peritendinous 1 mg daily Duration: 6 weeks Note: Not approved Peptide BPC 157 Peptide Pure Oral Spray AutoimmunityCare Research peptides pose considerable health and safety risks for anybody using them. This risk is magnified for drug tested athletes due to their status in sport and their significant risk for contamination BPC 157: Separating Fact from Fiction in Soft Tissue Injury Treatment Erik Schraga posted on the topic LinkedIn